With the rapid advances being made in our understanding of brain function and dysfunction, as well as their underlying biological mechanisms and psychological and social contexts, ECNP has expanded its journals programme to encompass two complementary platforms. Together the two journals provide publishing options that cover the spectrum of the applied and translational neurosciences:
- European Neuropsychopharmacology, published 12 times a year, focuses clinical and basic science contributions that advance our understanding of centrally acting agents, their connections to the biological bases of neuropsychiatric disorders, and the development and improvement of real-world treatments. The journal features the best research in drug development, pharmacology, brain and behavioural mechanisms, and clinical studies aimed at opening new avenues to recovery for those with brain disorders.
Editor-in-chief: Eduard Vieta
Associate editors: Jaanus Harro, Andreas Meyer-Lindenberg
For more information about European Neuropsychopharmacology and how to submit research for publication, please visit the journal homepage.
The impact factor (IF) of 2020 has increased from 3.853 to 4.600, almost a full point compared to 2019.
- Neuroscience Applied is ECNP’s fully open-access scientific journal, targeting the intersection between neuroscience, applications and new treatment horizons. The journal encompasses original basic, clinical and integrative research that has translational relevance for mental health, focusing especially on mechanisms of disorders, biological, psychological and social treatments, prevention and policies that apply a neuroscientific approach to brain disorders.
Editor-in-chief: Andreas Meyer-Lindenberg
Associate editors: Suzanne Dickson, Mark Millan
For more information about Neuroscience Applied, please visit the journal homepage.
For questions about submissions, please contact Andreas Meyer-Lindenberg via e-mail.
For ECNP President Gitte Moos Knudsen’s message about Neuroscience Applied, see here.